COVID-19 Diagnostic Testing Market Size to Surpass US$ 102.1 Billion by 2031 - Growth Plus Reports
Growth Plus Reports
6 min read
Growth Plus Reports
Newark, New Castle, USA, June 14, 2023 (GLOBE NEWSWIRE) -- The market analysis of the global COVID-19 diagnostic testing market was conducted by Growth Plus Reports in 2022 and is valued at US$ 81.7 billion. The market is expected to hit a revenue CAGR of 2.5% to reach US$ 102.1 billion by 2031.
Analysis of the global market for COVID-19 diagnostic testing indicates that during the forecast period, revenue share is likely to increase significantly. To find out if a person is currently infected with the SARS-CoV-2 virus, which produces COVID-19, COVID-19 diagnostic testing is performed.
Key Takeaways:
The increasing prevalence of Covid-19 is driving the market revenue share.
The government initiatives for an accurate diagnosis of Covid-19 are driving the market demand.
Collaborations among different companies are increasing the market revenue growth rapidly.
Product & Services, Sample Test, Test Type, End User, And Region
Regional Scope
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
Competitive Landscape
A list of the companies operating in the global market for COVID-19 diagnostic testing includes:
Danaher
Siemens Healthineers AG
Quidel Corporation
Thermo Fisher Scientific Inc.
PerkinElmer Inc.
bioMérieux SA
Market Drivers and Restraints:
The global COVID-19 diagnostic testing market revenue is driven by the rising prevalence of Covid-19, advancements in diagnostic technology, awareness among the population for early detection of disease, and rising government initiatives in precision diagnostics. Furthermore, the increasing R&D activities in the development of a point-of-care detection technique are contributing to the market revenue growth.
However, due to the cost margin pressure on the manufacturer and the limitations such as false positive results, the COVID-19 diagnostic testing market revenue growth is expected to be restrained.
Market Segmentation:
Segmentation By Product & Services
Based on the products & services, the reagents and kits segment dominates the global COVID-19 diagnostic testing market with a significant revenue share. This sizable revenue share is attributed to their vast utilization in Covid-19 testing and is required to perform PCR and antigen tests.
Segmentation By Sample Test
Based on the sample test, the nasopharyngeal swabs segment dominates the global COVID-19 diagnostic testing market with the largest revenue share. The significant revenue share is attributed to their critical component of COVID-19 diagnostic testing as well as nasopharyngeal swabs are considered a gold standard in COVID-19 disease detection.
Segmentation By Test Type
Based on test type, the molecular (PCR) testing segment accounts for the highest revenue share in the global COVID-19 diagnostic testing market due to its accuracy, cost-effectiveness, lesser chances of a false-positive result, high specificity, and sensitivity. Furthermore, the government's reliability on the molecular diagnostic test (PCR) results for an accurate count of COVID-19 patients is resulting in the segment's revenue growth of Covid-19 diagnostic testing and is expected to drive the segment revenue share significantly during the forecast period as well.
Based on mode, the lab-based segment accounts for the largest market revenue share in the global COVID-19 diagnostic testing market due to its specificity, affordability, and accuracy.
Segmentation By End-User
Based on end-users, the diagnostic center's segment is dominating the global COVID-19 diagnostic testing market with a sizable revenue share. To assist in the diagnosis and management of medical diseases, diagnostic facilities specialize in administering a variety of medical tests, including COVID-19 testing, attributing to the segment's revenue share.
Regional Growth Dynamics
Based on the region, North America, with the largest revenue share, dominates the global COVID-19 diagnostic testing market. This large share of revenue is attributed to the large population, rising awareness of testing, the prevalence of Covid-19, and well-established healthcare infrastructure.
Report Coverage
Growth Plus Reports carried out extensive market research on the COVID-19 diagnostic testing market globally. We examined the fundamental market characteristics, significant investment opportunities, regional growth patterns, ten-year revenue estimates, competing market players, and mergers and acquisitions.
Table of Content
INTRODUCTION
Market Ecosystem
Timeline Under Consideration
Historical Years – 2021
Base Year – 2022
Forecast Years – 2023 to 2031
Currency Used in the Report
RESEARCH METHODOLOGY
Research Approach
Data Collection Methodology
Data Sources
Secondary Sources
Primary Sources
Market Estimation Approach
Bottom Up
Top Down
Market Forecasting Model
Limitations and Assumptions
PREMIUM INSIGHTS
Current Market Trends (COVID-19 Perspective)
Key Players & Competitive Positioning (2022)
MARKET DYNAMICS
Drivers
Restraints
Opportunities
GLOBAL COVID-19 DIAGNOSTIC TESTING MARKET- ANALYSIS & FORECAST, BY PRODUCT & SERVICES
Instruments
Reagents & Kits
Service
GLOBAL COVID-19 DIAGNOSTIC TESTING MARKET- ANALYSIS & FORECAST, BY SAMPLE TYPE
Oropharyngeal (OP) Swabs
Nasal Swabs
Nasopharyngeal (NP) Swabs
Blood
Others
GLOBAL COVID-19 DIAGNOSTIC TESTING MARKET- ANALYSIS & FORECAST, BY TEST TYPE
Molecular (PCR) Testing
Antigen-based Testing
Antibody (Serology) Testing
Others
GLOBAL COVID-19 DIAGNOSTIC TESTING MARKET- ANALYSIS & FORECAST, BY MODE
Point-of-Care (PoC)
Lab-based
GLOBAL COVID-19 DIAGNOSTIC TESTING MARKET- ANALYSIS & FORECAST, BY END USER
Anticholesteremic Agents Market by Drug Class (Bile Acid Resins, Statins), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031
Glucose Elevating Agents Market by Products (Glucagon, Diazoxide), Indication (Hypoglycemia, Insulinoma), Route of Administration (Oral, Parenteral), Distribution Channel (Hospital Pharmacies, Retail Pharmacies), – Global Outlook & Forecast 2023-2031
Expat Health Insurance Market by Service Provider (Private, Public), Indication (Emergency Medical Evacuation, Maternity Coverage, Outpatient Coverage), Term Plan (Short-Term, Long-Term) – Global Outlook & Forecast 2023-2031
Veterinary Euthanasia Drugs Market by Animal Type (Companion Animals and Farm Animals), Route of Administration (Injectable Euthanasia Drugs, Inhalational Euthanasia Drugs) – Global Outlook & Forecast 2023-2031
MISME Syndrome Market by Treatment (Surgery, Radiotherapy, Pharmacotherapy) – Global Outlook & Forecast 2023-2031
About Us:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.
